论文部分内容阅读
目的:探讨当归注射液对慢性支气管炎伴肺气肿肺动脉高压的影响。方法:按入组顺序将50例患者平均分为两组。对照组25例采取常规西医治疗,治疗组25例加用当归注射液。结果:两组治疗后PASP、PADP和MPAP值均降低,与本组治疗前比较,差异均有统计学意义(P<0.05)。治疗后组间比较,差异均有统计学意义(P<0.05)。两组患者HAMD和HAMA评分较治疗前均下降。与本组治疗前比较,差异均有统计学意义(P<0.01,P<0.05),组间比较,差异均有统计学意义(P<0.05)。结论:当归注射液可有效改善慢性支气管炎伴肺气肿肺动脉高压患者的肺动脉压状态,临床疗效优于常规西医治疗。
Objective: To investigate the effect of Danggui injection on pulmonary hypertension with chronic bronchitis and emphysema. Methods: According to the order of the patients, 50 patients were divided equally into two groups. Control group, 25 cases of conventional Western medicine treatment group, 25 cases with angelica injection. Results: After treatment, the PASP, PADP and MPAP values were decreased in both groups, with statistical significance (P <0.05). After treatment, the differences between the two groups were statistically significant (P <0.05). HAMD and HAMA scores decreased in both groups before treatment. Compared with those before treatment, the differences were statistically significant (P <0.01, P <0.05). There was significant difference between the two groups (P <0.05). Conclusion: Angelica injection can effectively improve pulmonary arterial pressure in patients with chronic bronchitis and emphysema with pulmonary hypertension. The clinical effect is superior to that of conventional Western medicine.